Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans, Inhibits the Progression of Group B Streptococcal Arthritis

Glucuronoxylomannan (GXM), the principal constituent of the Cryptococcus neoformans capsule, modulates the inflammatory response of human monocytes in vitro. Here we examine the efficacy of GXM as a novel anti-inflammatory compound for use against experimental septic arthritis. Arthritis was induced...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Tissi, Luciana, Puliti, Manuela, Bistoni, Francesco, Mosci, Paolo, Kozel, Thomas R., Vecchiarelli, Anna
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2004
Assuntos:
Molecular Pathogenesis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC523051/
https://ncbi.nlm.nih.gov/pubmed/15501766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.72.11.6367-6372.2004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares